Enrique Curbelo was delighted. Selling cannabis has allowed the affable 76-year-old to keep his privately owned pharmacy in Montevideo open in a market dominated by big chains.
“I had to sell what they didn’t sell,” Curbelo told reporters. “For me it’s like selling aspirin.”
It has been this way for a year now.
Every Wednesday, Ismael Fernandez receives a WhatsApp message from his local pharmacist telling him a new stock of cannabis has arrived.
After leaving work, he heads there and buys the 10 grams that Uruguayan law permits for 400 Uruguayan pesos (US$12.92). Fernandez then heads home and rolls a joint “to relax” with his partner Stefania Fabricio.
No longer do they need to surreptitiously contact a dealer and pay more for Paraguayan or Brazilian marijuana that has been “pressed, mixed [and is] sometimes very bad and full of chemicals,” he said.
“Now it’s much easier than when it started,” said Fernandez, a 31-year-old who works for a cleaning company.
It has been four-and-a-half years since marijuana use became legal in Uruguay and a year since it has been sold in pharmacies — up to 40 grams a month per person.
Initially, there was insufficient supply, leaving people standing in long lines as stocks sometimes ran out. Pharmacies are better prepared now.
“They send you a message with a number, which you use later to go and collect it, and in my pharmacy you can order it online,” said Fernandez, the father of a three-year-old.
“It’s good quality,” but not too strong, 31-year-old hairdresser Fabricio said. “It doesn’t send your head spinning, but it’s not meant to. You get a hit, but you can still do things perfectly.”
She said she feels “privileged” to live in a country that enacted a law to “get tons of people out of the black market.”
As a result, the stigma attached to those who smoke pot is changing, “albeit slowly,” she said.
The system is simple: To buy cannabis in a pharmacy you must be at least 18, live in Uruguay and sign up as a “buyer” at the post office.
An initial stumbling block arose when banks refused to work with establishments selling cannabis due to international rules against drug trafficking.
However, the country plowed on and last year it became the first in the world to fully legalize the sale of marijuana.
However, Curbelo had to get over his own prejudices before deciding to join the select band of pharmacies selling the plant. There are 14, half of them in the capital, serving 24,812 registered buyers.
Users can choose between two brands and two types of cannabis — Cannabis sativa and Cannabis indica — that are provided by an official distributor.
Customers are generally not the stereotypical grubby-looking student or idle waster. On one day in Curbelo’s store they included two young women, a man in his 50s and an older lady — “normal people,” the pharmacist said.
Official statistics showed that 70 percent of buyers are male and 49 percent are between the ages of 18 and 29.
To keep anyone from exceeding their monthly allowance, a fingerprint machine is used to register every sale.
Along with the ability to purchase cannabis in a pharmacy, Uruguayans have the right to grow their own — up to a six-plant maximum — or join a cannabis club, which can have up to 45 members and 99 plants.
Federico Corbo, a 41-year-old gardener, grows cannabis in his garden on the outskirts of Montevideo. He experiments by crossing species in an attempt to improve quality and optimize the flowering period.
He is not impressed with the quality on offer in pharmacies.
“It’s not the worst, but it’s low,” Corbo said, insisting that quality control needs to be improved.
“Marijuana that doesn’t reach the minimum standards — with crushed flowers, no aroma, low quality — shouldn’t be sold in the pharmacy,” he said.
“Maybe, as I’m a grower, I’m very demanding, but there is a cost associated to the product and it must be offered to the public in the best way possible,” he added.
An average cultivator or club member supplies cannabis to two other people, while those who buy it in a pharmacy share it with one other, the Uruguayan Institute of Cannabis Regulation and Control said.
“Approximately half of marijuana users have access to regulated cannabis,” the institute said, adding that the rest prefer to continue buying the drug on the black market, put off by the need to register as a user.
“It’s wrong — if they legalize it they have to do so in a way in which the state doesn’t keep a paternalistic role in overseeing how much you smoke or stop smoking,” said one user, who wished to remain anonymous.
The 48-year-old lawyer simply does not trust the authorities, pointing to the danger a change of government could bring, or even the return of dictatorship.
“Right now that seems impossible, but you can never discount it,” he said.
‘BIG LOSS’: This year might see the last generation of Huawei’s Kirin chips, as their production would stop next month because they are made using US technology Chinese tech giant Huawei Technologies Co (華為) is running out of processor chips to make smartphones due to US sanctions and would be forced to stop production of its own most advanced chips, a company executive has said, in a sign of growing damage to Huawei’s business from US pressure. Huawei, one of the biggest producers of smartphones and network equipment, is at the center of US-Chinese tension over technology and security. Washington last year cut off Huawei’s access to US components and technology, and those penalties were tightened in May, when the White House barred vendors worldwide from using US
’WHITE BOX’: The open platform would give local firms access to Cisco’s cloud-based mobile network to develop 5G telecom equipment and tap into the global market The Ministry of Economic Affairs (MOEA) yesterday introduced a new 5G “open lab” in collaboration with US-based information technology and networking giant Cisco Systems Inc to address the rapidly growing “white box” 5G networking equipment market. The open lab will be a platform where Taiwanese manufacturers can access Cisco’s cloud-based mobile network to develop their own 5G telecom equipment, such as small-cell base stations, network switches, modems and Internet of things (IoT) devices, a ministry statement said. The open platform would allow Taiwanese manufacturers to tap into the lucrative 5G telecom equipment market, which was previously monopolized by Nokia Oyj, Ericsson AB
Nintendo Co is raising its target for Switch production to about 25 million units this fiscal year, people familiar with the matter said, as the ongoing COVID-19 pandemic keeps lifting demand and component shortages ease. The Kyoto, Japan-based company, which in April hiked orders to 22 million units by March next year, is asking partners to tack on another few million units, said the people, who did not want to be identified discussing internal goals. Assembly partners plan to work at maximum capacity through December. The new production target suggests that Nintendo is likely to outperform its Switch sales forecast of 19 million
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday reported that revenue last month expanded 25 percent annually, but fell 12.8 percent month-on-month to NT$105.96 billion (US$3.59 billion). In the first seven months of this year, the chipmaker’s revenue surged 33.6 percent to NT$727.26 billion, compared with NT$544.46 billion a year earlier. TSMC has said it aims to grow its revenue by more than 20 percent this year. The company has since May 15 stopped taking new orders from Huawei Technologies Co (華為), its second-biggest customer after Apple Inc, due to the US’ restrictions on exports containing US technologies. TSMC has no plans to